DUBLIN (AP) — DUBLIN (AP) — Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $25.1 million in its third quarter.

The Dublin-based company said it had a loss of 6 cents per share. Losses, adjusted for stock option expense, were 5 cents per share.

The biopharmaceutical company posted revenue of $42.3 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $43.8 million.

In the final minutes of trading on Wednesday, the company's shares hit 60 cents. A year ago, they were trading at 69 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN